AtriCure (ATRC) Revenue (2010 - 2026)

AtriCure (ATRC) has reported Revenue for 17 consecutive years, with $153.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 12.83% year-over-year to $153.6 million in Q2 2026; TTM through Jun 2026 was $569.6 million, a 13.94% increase from a year earlier, with the FY2025 full-year figure at $534.5 million, up 14.88% from the prior year.
• Revenue was $153.6 million for Q2 2026 at AtriCure, up from $141.2 million in the prior quarter.
• Over five years, Revenue peaked at $153.6 million in Q2 2026 and troughed at $74.6 million in Q1 2022.
• A 5-year average of $112.5 million and a median of $112.4 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue rose 25.81% in 2022 and rose 12.83% in 2026, its largest moves.
• Over 5 years, Revenue stood at $88.0 million in 2022, then climbed by 21.03% to $106.5 million in 2023, then grew by 16.64% to $124.3 million in 2024, then advanced by 13.05% to $140.5 million in 2025, then grew by 9.33% to $153.6 million in 2026.
• The last three Revenue figures came in at $153.6 million (Q2 2026), $141.2 million (Q1 2026), and $140.5 million (Q4 2025), per Business Quant data.